Mid-Illinois Hematology and Oncology Associates, Ltd. — Normal, Illinois

Mid-Illinois Hematology and Oncology Associates, Ltd. is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Mid-Illinois Hematology and Oncology Associates, Ltd. has participated in 2 clinical trials.

Therapeutic areas: Renal Cell Carcinoma, Breast Cancer.

Sponsors: Accelerated Community Oncology Research Network, NCIC Clinical Trials Group.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Illinois Hematology and Oncology Associates, Ltd.?

Mid-Illinois Hematology and Oncology Associates, Ltd. has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Illinois Hematology and Oncology Associates, Ltd. conducted?

Mid-Illinois Hematology and Oncology Associates, Ltd. has 2 clinical trials on record. Their work covers Renal Cell Carcinoma, Breast Cancer.

Is Mid-Illinois Hematology and Oncology Associates, Ltd. accredited by Crixeo Health?

Mid-Illinois Hematology and Oncology Associates, Ltd. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Illinois Hematology and Oncology Associates, Ltd.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.